Skip to content

Change in AR at other companies

Pfizer logo
PfizerPFE
$65.75M+141%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
-$39.8M-123%
Incyte logo
IncyteINCY
$27.03M+187%
BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
$7.16M-87.6%
Precigen logo
PrecigenPGEN
$22.49M+12,950%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
-$19M-90.0%

Other financials

Income statement

See full
Revenue$20.7M+138%
Gross profit$19.4M+154%
Operating income-$110.0M-3.2%
Net income-$99.1M-11.0%
EPS (diluted)-$1.69-9.0%

Balance sheet

See full
Cash & equivalents$113.6M+43.9%
Total debt$35.7M-32.5%
Total equity$1.1B-24.4%
Total assets$1.2B-23.8%

Cash flow

See full
Operating cash flow-$118.9M-6.7%
CapEx$769.0K+0.4%
Free cash flow-$119.7M-6.6%

Valuation

See full
Market cap$2.12B+18.1%
Enterprise value$2.04B+15.2%
P/S32.1×-16.4×

Profitability

See full
Gross margin90%+2.5pp
Operating margin-720%-204pp
Net margin-639.8%
FCF margin-582.5%-185pp

Returns & leverage

See full
Return on equity-32.8%
Debt / equity0.0×
Current ratio14.2×-4.3×

Where this comes from

Reported directly by Agios Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsReceivable.

The official record: Agios Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agios Pharmaceuticals's change in ar.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agios Pharmaceuticals's change in AR?
Agios Pharmaceuticals (AGIO) reported change in AR of $5.56M in Q1 2026.
How has Agios Pharmaceuticals's change in AR changed year-over-year?
Agios Pharmaceuticals's change in AR increased by 826.1% year-over-year, from -$765K to $5.56M.
What does change in AR mean?
Increase or decrease in amounts owed by customers — the primary working capital driver for many businesses.